Skip to main content

ZENITH A011-14 (A Phase 3, Randomized, Double-Blind, Placebo- Controlled Study to Evaluate Sotatercept When Added to Maximum Tolerated Background Therapy in Participants With Pulmonary Arterial Hypertension (PAH) WorldHealth Organization (WHO)

Clinical Trial Grant
Duke Scholars

Administered By

Medicine, Pulmonary, Allergy, and Critical Care Medicine

Awarded By

Acceleron Pharma

Start Date

July 20, 2022

End Date

February 14, 2026
 

Administered By

Medicine, Pulmonary, Allergy, and Critical Care Medicine

Awarded By

Acceleron Pharma

Start Date

July 20, 2022

End Date

February 14, 2026